Celgene Revenue and Competitors
Estimated Revenue & Valuation
- Celgene's total funding is $103.5M.
Employee Data
- Celgene has 2734 Employees.
- Celgene grew their employee count by -13% last year.
Celgene's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO, Celgene Global Health and CMO, Celgene Corporation | Reveal Email/Phone |
2 | Head Mobile and Corporate Websites | Reveal Email/Phone |
3 | Head, Clinical Reseach and Development I&I | Reveal Email/Phone |
4 | Associate Director, External Manufacturing | Reveal Email/Phone |
5 | Associate Director Technical Operations | Reveal Email/Phone |
6 | Director | Reveal Email/Phone |
7 | Assoc. Director, Cell Therapy External Manufacturing & Strategic Sourcing, Celgene | Reveal Email/Phone |
8 | Director, Head EHS | Reveal Email/Phone |
9 | Senior Director, Global Commercialization, Myeloid | Reveal Email/Phone |
10 | Associate Director External API QA Operations | Reveal Email/Phone |
Celgene Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Celgene?
Celgene Corporation, headquartered in Warren, New Jersey, is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.
keywords:N/A$103.5M
Total Funding
2734
Number of Employees
N/A
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Celgene News
2022-04-20 - Thalassemia Market Size, Outlook And Forecast | Bluebird bio ...
Bluebird bio, Acceleron Pharma, Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, Kiadis Pharma,...
2022-04-20 - Myeloproliferative Disorders Drugs Market Size, Outlook And ...
Celgene, Bristol-Myers Squibb, Gamida Cell, Incyte, Geron, Promedior, Johnson & Johnson. This comprehensive Myeloproliferative Disorders...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $849.8M | 4228 | 2% | N/A |